Akesson, Lina <br/><br/>
VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.  [electronic resource] 

 -  Endocrinology  Feb 2005 
 - 744-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0013-7227 
<br/><br/><label>Standard No.: </label>10.1210/en.2004-0504  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipocytes--drug effects<br/>Animals<br/>Cyclic AMP-Dependent Protein Kinase Type II<br/>Cyclic AMP-Dependent Protein Kinases--metabolism<br/>Gene Expression<br/>Lipolysis--drug effects<br/>Male<br/>Nerve Growth Factors--metabolism<br/>Neuropeptides--metabolism<br/>Neurotransmitter Agents--metabolism<br/>Peptide Fragments--pharmacology<br/>Pituitary Adenylate Cyclase-Activating Polypeptide<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Cell Surface--antagonists & inhibitors<br/>Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide<br/>Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I<br/>Receptors, Vasoactive Intestinal Peptide--agonists<br/>Receptors, Vasoactive Intestinal Peptide, Type II<br/>Receptors, Vasoactive Intestinal Polypeptide, Type I<br/>Vasoactive Intestinal Peptide--metabolism